SOCIETY SESSION: BDA. NEW ONCOLOGY DRUGS – APPROVAL PROCESS AND REIMBURSEMENT SYSTEMS IN EUROPE

Different availability of new oncologic drugs in Europe - A medical oncologist perspective

H. Zwierzina